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Abstract 
MicroRNAs can affect the protein translation using nine mechanistically different 
mechanisms, including repression of initiation and degradation of the transcript. There is a hot 
debate in the current literature about which mechanism and in which situations has a 
dominant role in living cells. The worst, same experimental systems dealing with the same 
pairs of mRNA and miRNA can provide ambiguous evidences about which is the actual 
mechanism of translation repression observed in the experiment. We start with reviewing the 
current knowledge of various mechanisms of miRNA action and suggest that mathematical 
modeling can help resolving some of the controversial interpretations. We describe three 
simple mathematical models of miRNA translation that can be used as tools in interpreting the 
experimental data on the dynamics of protein synthesis. The most complex model developed 
by us includes all known mechanisms of miRNA action. It allowed us to study possible 
dynamical patterns corresponding to different miRNA-mediated mechanisms of translation 
repression and to suggest concrete recipes on determining the dominant mechanism of 
miRNA action in the form of kinetic signatures. Using computational experiments and 
systematizing existing evidences from the literature, we justify a hypothesis about co-
existence of distinct miRNA-mediated mechanisms of translation repression. The actually 
observed mechanism will be that acting on or changing the limiting “place” of the translation 
process. The limiting place can vary from one experimental setting to another. This model 
explains the majority of existing controversies reported. 
 
Introduction 
MicroRNAs (miRNAs) are short (21-23nt long) non coding RNAs that are currently 
considered as key regulators of a wide variety of biological pathways, including development, 
differentiation and tumorogenesis. Recently, remarkable progress has been made in 
understanding miRNA biogenesis, function and mode of action. Mature miRNAs are 
incorporated into the RISC complex, whose key component is an Argonaute protein, and 
consequently regulate gene expression by guiding the RISC complex toward specific target 
mRNAs (see Figure 13.1). However, the exact mechanism of this regulation is still a matter of 
debate. In the past few years, several possible mechanisms have been documented 
[5,9-10,13,16,19,21,32,41,57,68]. The most documented mechanisms are negative post-
transcriptional regulation of mRNA by mRNA translation inhibition and/or mRNA decay, 
however, some observations show that miRNAs may also act at the transcriptional level.  
There is a big controversy in the current literature about which mechanism and in which 
situations has a dominant role in living cells. The worst, same experimental systems dealing 
with the same pairs of mRNA and miRNA can provide controversial evidences about which is 
the actual mechanism of translation repression observed in the experiment. In this chapter we 
claim that using mathematical modeling can shed light on resolving contradicting experiment 
interpretations. 
The structure of the chapter is the following: 
First, we review the whole corpus of available experimental evidences suggesting existence of 
various mechanisms of miRNA action. Second, we give a detailed description of three 
mathematical models all describing the process of protein translation in the presence of 
miRNA. We start with the simplest linear model, suggested before by Nissan and Parker [62]. 
By analytical analysis of this simple model we demonstrate the importance of exploiting not 
only the stationary properties but also the dynamical properties in interpreting the experiments 
on miRNA-mediated silencing of translation. The second model of protein translation, also 
suggested first by Nissan and Parker and analyzed in [90] shows how recycling of initiation 
factors and ribosomal subuntis can be taken explicitly into account and to what limitation 
effects this can lead. We finalize the chapter by describing a mathematical model in which all 
nine known mechanisms of miRNA action are taken into account, developed by the authors of 
this chapter [24, 60]. Based on this model, we formulate practical recipes of distinguishing 
mechanisms of miRNA action by observing stationary and dynamical properties of three 
quantities: total amount of mRNA, amount of protein synthesized and the average number of 
ribosomes located on one transcript. 
We analyze all three models following a common recipe. The purpose of the analysis is to 
obtain understanding of how the stationary states and the relaxation times of the model 
variables depend on model parameters. Though analysis of the stationary state is a well-
known approach, analysis of relaxation time is a relatively poorly explored method in systems 
biology. By definition, the relaxation time is the characteristic time needed for a dynamic 
variable to change from the initial condition to some close vicinity of the stationary state. The 
relaxation time is a relatively easily observable quantity, and in some experimental methods it 
is an essential measurement (relaxometry, for example, see [75]). Most naturally the 
relaxation time is introduced in the case of a linear relaxation dynamics. For example, if a 
variable follows simple dynamics in the form  teAtx  1)( , where A is the steady-state 
value of x,  then the relaxation time is 


1
  and it is the time needed for x to increase from 
the zero initial value to approximately 1/e ≈ 63% of the A value. Measuring the approximate 
relaxation time in practical applications consists in fitting the linear dynamics to the 
experimental time curves and estimating for example, see [27]. 
The most complete model allows us to simulate the scenario when several concurrent miRNA 
mechanisms act at the same time. We show that in this situation interpretation of a biological 
experiment might be ambiguous and dependent on the context of the experimental settings. 
This allows us to suggest a hypothesis that most of the controversies published in the 
literature can be attributed to the fact of co-occurrence of several miRNA mechanisms of 
action, when the observable mechanism acts on the limiting step of protein translation which 
can change from one experiment to another.  
 
1. Review of published experimental data supporting each of proposed mechanisms 
of microRNA action 
Protein translation is a multistep process which can be represented as sequence of stages 
(initiation, ribosome assembly, elongation, termination) involving circularization of mRNA, 
recruiting the mRNA cap structure and several protein initiation factors and ribosomal 
components. The process of normal translation can be regulated by small non-coding 
microRNAs through multiple mechanisms (Figure 13.1).  
Here we are reviewing available experimental data on all reported mechanisms of microRNA 
action, grouping them in a way which elucidates the main details supporting each of these 
proposed mechanisms. 
M1: Cap-40S Initiation Inhibition 
Inhibition of cap recruitment as a suggested mechanism of microRNA repression was initially 
proposed by Pillai, et al [69], and since that time this mechanism was one of the most 
frequently identified [17,19,29,40,80,91]. 
The main evidence in favor of the cap-recognition and 40S assembly inhibition model was 
that IRES-driven or A-capped mRNA (see Figure 13.1 for definitions of these terms) are 
refractory to microRNA inhibition, together with a shift toward the light fraction in the 
polysomal gradient. According to this, an initiation mechanism upstream of eIF4G 
recruitment by eIF4E was postulated and it was hypothesised that it suppresses the 
recognition of the cap by eIF4E. The very recent studies [17, 91] detailed GW182 
involvement in the initiation suppression via cap-40S association, thus providing additional 
evidence for this mechanism. 
M2: 60S Ribosomal Unit Joining Inhibition 
It has also been proposed that microRNA could act in a later step of initiation, i.e., block the 
60S subunit joining. This hypothesis, initially suggested by Chendrimada et al. [11],  was next 
supported by in-vitro experiments showing a lower amount of 60S relative to 40S on inhibited 
mRNAs, while toe-printing experiments show that 40S is positioned on the AUG codon [85]. 
It is important to point out that, strictly speaking, there is no proof that miRNA affects the 
scanning for the AUG codon in this work, although some works interpret this data as an 
inhibition of scanning [62]. 
M3: Elongation Inhibition 
Historically, the inhibition of translation elongation mechanism was the first proposed 
mechanism for microRNA action [64]. The major observation supporting this hypothesis was 
that the inhibited mRNA remained associated with the polysomal fraction, which was 
reproduced in different systems [25,45,54,67]. The idea of a post-initiation mechanism was 
further supported by the observation that some mRNAs can be repressed by microRNA even 
when their translation is cap-independent (see Figure 13.1, mRNAs with an IRES or A-
capped) [4,37,53,67,54]. 
Actually, in the work by Olsen and Ambros [64] there is no data supporting elongation 
inhibition rather than other post-initiation mechanisms (e.g. nascent polypeptide degradation), 
because the main conclusion is derived only by studying the polysomal profiles. But some 
evidences can be found in the work by Gu et al. [25], describing that on the same mRNA, 
when the ORF is prolongated downstream the binding site of miRNA (mutation in the stop 
codon), the inhibition by a miRNA is lost. If a rare (slow) codon is introduced upstream the 
binding site, the inhibition is relieved, which shows that the presence of actively translating 
ribosomes on the binding site impairs the inhibition by miRNA. The presence of a normal 
polysomal distribution of the inhibited mRNA and sensitivity to EDTA 
(ethylenediaminetetraacetic acid) and puromycin indicating functional, translating polysomes, 
allowed the authors to suggest the “elongation” model.  Also some data of Maroney et al. 
[54], could also imply that elongation is slowed down by microRNA (as the ribosome stays 
longer on the inhibited mRNA), but the authors discussed this point critically and were not 
able to reproduce it in vitro. 
 
 
Figure 13.1. Interaction of microRNA with protein translation process. Several (from nine documented) 
mechanisms of translation repression are shown: M1) on the initiation process, preventing assembling of the 
initiation complex or recruiting the 40S ribosomal subunit; M2) on the ribosome assembly; M3) on the 
translation process; M7,M8) on the degradation of mRNA. There exist other mechanisms of microRNA action 
on protein translation (transcriptional, transport to P-bodies, ribosome drop-off, co-translational protein 
degradation and others) that are not visualized here. Here 40S and 60S are light and heavy components of the 
ribosome, 80S is the assembled ribosome bound to mRNA, eIF4F is an translation initiation factor, PABC1 is 
the Poly-A binding protein, “cap'' is the mRNA cap structure needed for mRNA circularization (which can be the 
normal m7G-cap or artificial modified A-cap). The initiation of mRNA can proceed in a cap-independent 
manner, through recruiting 40S to IRES (Internal Ribosome Entry Site) located in 5’UTR region. The actual 
work of RNA silencing is performed by RISC (RNA-induced silencing complex) in which the main catalytic 
subunit is one of the Argonaute proteins (AGO), and miRNA serves as a template for recognizing specific 
mRNA sequences.  
 
M4: Ribosome Drop-off (premature termination) 
First (and seems to be the only one till today) evidence of this mechanism was done by 
Petersen et al. [67], who observed no difference in polysomal profile in the presence of 
miRNA. Addition of puromycin, which necessitate peptidyl transferase activity to act, didn’t 
change the polysomal profile in the presence or in the absence of the miRNA. The authors 
have concluded that polysomes are actively translating even in presence of miRNA. They 
were not be able to detect any peptide by radiolabelling and therefore postulated the ribosome 
drop-off mechanism.  
However, Wang et al. [84] presented data also supporting premature termination: the read-
through codon-stop and more rapid loss of polyribosome upon initiation block.  
M5: Co-translational Nascent Protein Degradation 
Initially, the idea of nascent protein degradation was proposed by Nottrott et al. [63], 
according to the presence of inhibited mRNA and AGO protein in polysomes, which suggests 
the action of miRNA on actively translated mRNA. However, no nascent peptide has ever 
been experimentally demonstrated [63,67,68,84]; thus the nascent polypeptide degradation, if 
it exists, should occur extremely rapidly after the synthesis. Anyhow, being able to 
immunoprecipitate the nascent polypeptide together with the mRNA and the polysome in the 
case of normal translation, the authors failed to do so in the case of miRNA inhibition [63]. 
Pillai et al. in [68] showed that this degradation, if exists, should be proteasome-independent, 
and no specific protease or complex involved in this polypeptide degradation has ever been 
identified. Data supporting nascent polypeptide degradation are the following: a) 
sedimentation of mRNA together with miRNA-RISC complexes in actively translating 
(puromycin-sensitive) polysomes; b) blocking the initiation (in a cap-dependent manner), 
resulted in a shift in polysomal profile, suggesting that the repressed mRNA is actively 
transcribed. In Wang et al. [84] the authors also support nascent protein degradation showing 
polysomal distribution with puromycin sensitivity, but in the same paper they also present 
data supporting premature termination. Maroney et al. [54] and Gu et al. [25] presented 
experimental data which are very coherent with this line though not concluding that this 
mechanism is the dominating one: presence of miRNA/mRNA complex in polysomes, 
sensitivity to different conditions is an indication of translating ribosomes.   
M6: Sequestration in P-bodies 
An effect of sequestration of mRNA targeted by AGO-microRNA complex in cytoplasmic 
structures called P-bodies was initially shown in [69,78]. Next this result was confirmed in 
many studies characterising P-bodies as structures where the translational machinery is absent 
and the degradation machinery is functional [8,33,47,50,51,66,69,78]. The main propositions 
about P-bodies' function was that they sequestrate targeted mRNA apart from translational 
machinery, or that P-bodies give a kinetics advantage for mRNA decay (local concentration 
of all needed enzymes). Two additional important points were elucidated in [14], showing 
that mRNA localised in the P-bodies, can be still associated with polysomes, and also that 
miRNA silencing is still possible when P-bodies are disrupted. This led to the conclusion that 
P-bodies are not required for but rather a consequence of microRNA-driven RNA degradation 
or translational inhibition. This conclusion is also supported by other studies [48] and is 
mostly accepted today. Moreover, only a small portion of miRNA, mRNA and RISC complex 
is localised inside macroscopic P-bodies [48,69].  
M7: mRNA Decay (destabilisation) 
Recently, starting from the first description by Lim et al. [49], a lot of data has revealed 
miRNA-mediated mRNA decay (destabilization) of targeted mRNA without direct cleavage 
at the binding site [2,3,6,15,34,49,77,83,87].  Also, most of the authors note that only a slight 
protein decrease can be obtained by translational inhibition only. When the protein level 
decreases by more than 33%, mRNA destabilization is the major component of microRNA-
driven silencing [2]. Anyhow, all these data, concordant in the main point (mRNA decay 
mechanism), are different in details of its concrete mechanism (decay by mRNA 
deadenylation, decapping, or 5′ to 3′ degradation of the mRNA). In the review of Valencia-
Sanchez et al. [81], it is concluded that the decapping followed by 5’->3’ degradation is the 
most plausible mechanism for the miRNA inhibition, while deadenylation could lead only to a 
decrease in the initiation efficiency by disrupting the loop between polyA and cap. Behn-
Ansmant et al. [6], showed that GW182, an AGO partner in the microRNA pathway, triggers 
deadenilation and decapping of bound mRNA, which leads to mRNA decay. Filipowicz et al. 
[19] supports the idea of the degradation running mostly in 5’->3’ direction after 
deadenylation and decapping, in contradiction to [87], where it is claimed that deadenylation 
is the principal cause of the mRNA decay but degradation goes first in the 3’->5’ way. The 
latter work also indicated that the degradation mechanism is supposed to be only an addition 
to the translational inhibition and that translational inhibition has the same efficiency with or 
without degradation. Coller and Parker in 2004 proposed that as the poly(A) tail can enhance 
translation rates and inhibit mRNA decay, then the increases of deadenylation rates by 
miRNA/RISC could be counted as additional mechanism by which translation repression and 
mRNA decay could be stimulated [12].  Finally, Eulalio et al. showed that there could be two 
different cases in mRNA degradation by microRNA: in one the ongoing translation is 
required for the decay, and in the second the decay occurs in the absence of active translation, 
and assume that this depends on mRNAs undergoing the decay [15]. 
M8: mRNA Cleavage 
mRNA cleavage (similar to what is observed with siRNA) can be observed when the 
sequence of microRNA is completely or almost completely complementary to its target 
binding site. The first proposition for this mechanism was made for plants [52,73], and since 
that time, the miRNA-mediated mRNA cleavage was proved to be very common for plants, 
and much more rare in animals [31,89].  
Though the most of known mammalian microRNAs are only partially complementary to their 
targets, there is some data on miRNA-mediated mRNA cleavage, for example, for miR-196 
[89]. A few other works (e.g., in mammals [1,81] or in C.elegans [3]) also  mentioned 
cleavage as a possible mechanism of microRNA repression in animals. 
M9: Transcriptional Inhibition through microRNA-mediated chromatin reorganization 
following by gene silencing 
Although the first publication for siRNA-mediated transcriptional repression [61] was made 
in 2004, the first publication proving miRNA-mediated transcriptional repression in 
mammalian cells appeared only recently [38]. Around this time also appeared the first 
publication for miRNA-mediated transcriptional activation, showing that microRNA-373 
induces expression of genes with complementary promoter sequences [71]. Since then very 
few evidences of miRNA-directed transcriptional gene silencing (TGS) in mammalian cells 
were obtained [38,86].   
 
2.2. Controversies between the miRNA-mediated mechanisms of translation 
repression 
It is important to note that it is extremely difficult to discriminate experimentally between 
different potential post-initiation mechanisms, such as elongation inhibition, premature 
ribosome dissociation (”ribosome drop-off”) or normal elongation with nascent polypeptide 
degradation. Both elongation slowing down and nascent polypeptide degradation are 
supported by the fact that the mRNA-polysomal association is puromycin-sensitive, 
indicating polysomes' activity [54,63] and by the observed requirement for microRNA 
binding in the unstranslated region [25]. Premature ribosome dissociation is supported by 
decreased read-through of inhibited mRNA [67]. Both ribosome drop-off and ribosomal 
“slowing down” are supported by the slight decrease in the number of associated ribosomes 
[54,63]. But, eventually with premature drop-off, the polysomal profile will not be the same 
as in the case of nascent protein degradation, as one should have less ribosomes per mRNA. 
Summarizing overview on the proposed mechanisms, we briefly emphasize the main 
controversial data. 
1. First of all, even the question at which level (transcriptional, translational, etc) the 
microRNA action takes place is still strongly debated. The most frequently reported, but also 
very contradictory in details, is the mechanism of gene repression by microRNAs occurring at 
the level of mRNA translation (this includes mechanisms of arrest  at initiation and elongation 
steps, ribosome drop-off and nascent polypeptide degradation),  but repression at the level of 
mRNA (before translation) have been also proposed as the principal one in many studies (this 
includes mechanisms of microRNA-mediated mRNA decay, sequestration of target mRNAs 
in P-bodies and rare in animals but frequent in plants mechanism of target mRNA cleavage). 
Moreover, it was proposed that some microRNAs mediate chromatin reorganization followed 
by transcriptional repression, which involves mechanisms strikingly different from the 
previous modes of repression. Finally, the transcriptional activation by microRNA [38,71] 
and translational activation by microRNA have been also proposed [65,82]. 
 2. Currently, the action of microRNAs at the level of initiation of translation seems to be the 
most favourite one accordingly to many recent publications. Anyhow, the experimental data, 
supporting this mechanism, are also controversial in the result interpretations of different 
groups suggesting this mechanism. For example, it has been proposed that AGO2 protein 
could interact with the cap via de eIF4E-like domain and therefore compete with eIF4E for 
binding the cap [40]. However, this has been weakened by the recent finding that this domain 
could be involved in the binding with GW182, an important protein for miRNA action, and 
by crystallographic analysis showing that the folding will not allow such a interaction with the 
cap [17,39].  
The main observation supporting the initiation mechanism is that mRNA with IRES or A-cap 
can't be inhibited by microRNA, but in the considerable number of works it was shown that 
some mRNAs can be repressed by a microRNA even when their translation is cap-
independent [4,37,53,67]. 
3. For blocking the 60S subunit joining mechanism, it was shown that eIF6, an inhibitor of 
60S joining, is required for microRNA action [11], but this was contradicted by other studies 
[17]. 
4. An interesting observation was reported in [42] about that the same mRNA targeted by the 
same microRNA can be regulated either at the initiation or the elongation step depending on 
the mRNA promoter. But next, using the same promoter described in [42], as leading to the 
initiation mechanism, the authors suggests the “elongation” model, according to the 
polysomal distribution on the inhibited mRNA [25]. 
5. Different results about mechanisms of microRNA action were obtained depending on the 
transfection method of the inhibited mRNA [53]. 
6. Karaa et al. describes the VEGF gene, which is endogenously regulated by a miRNA, 
miR16, acting on an IRES (see Figure 13.1 legend) [37]. VEGF is translated from one of two 
IRES, and only one of these IRES allows inhibition by miR16. Therefore, inhibition by 
microRNA is possible even in IRES-driven translation, but not for all IRES-driven cases, 
even if those two IRES have been described as similar. 
7. Kozak et al., reviewing different papers about miRNA-mediated inhibition, claimed a lot of 
experiments to be faulty [43] and reported that only few studies are based on reliable 
experiments could be considered, namely [11,29,40,55,83,85]. The statement of the author 
that “other suggested mechanisms are not mentioned here because the speculations greatly 
exceed the facts” seems to concern [53,63,67,69].Together with this, the author is very critical 
about interpretations of the IRES experiments. 
8. Olsen et al. has described inhibition of elongation step, based on the presence of polysomal 
distribution [64]. But, actually, there is no additional data supporting elongation inhibition 
rather than nascent polypeptide degradation, because in both works the main (and different!) 
conclusion is driven only by studying the polysomal profiles. 
9. In several studies it was shown that degradation and translational arrest can be coupled in 
many systems [15,17,18,69,87], but here the situation is also not completely understood: 
some mRNAs are repressed mostly at the translational level, others mostly at the stability 
level (with or without a requirement for concurrent translation inhibition), and some at both 
levels [1]. In some works it is suggested that microRNA-mediated mRNA decay is a 
consequence of translational repression, the other group of studies suggests that neither the 
destabilisation is a consequence of translational arrest, nor the translational repression is a 
consequence of degradation, but that the two mechanisms are concurrently occurring 
[16,17,91]. It has been concluded that the relative contributions of translational repression and 
decay differ depending on the presence or absence of the poly(A) tail [17]. However, in 
deciding whether the deadenylation is the cause or consequence of silencing, the authors 
again present controversial data interpretations [79]. 
Thus, the experimental data and summarizing conclusions about the mechanism by which 
microRNA repress mRNA expression are highly controversial, and though arise a question 
about interrelations between the different mechanisms and their possible concomitant action, 
do not consider it in the frame of one unique mechanism of  microRNA action. 
Using a series of mathematical models with increasing complexity, we show how 
mathematical modelling can help in interpreting the experimental results and even suggest 
some explanations of the ambiguous observations. 
 
3. Modeling notations and assumptions 
In this chapter we consider three mathematical models of miRNA action of increasing 
complexity:  
1. The simplest linear model of protein translation. This model was first suggested in 
[62]. It allows distinguishing two types of miRNA-mediated mechanisms: those acting 
at the very early stage of translation initiation and those acting at a later stage. 
2. Non-linear model of protein translation taking into account recycling of ribosomes 
and initiation factors. This model was first suggested in [62]. It allows distinguishing 
four types of miRNA-mediated mechanisms: acting at the very early stage of 
initiation, later stage of initiation, ribosome assembly step, elongation and termination 
(considered together as one step of translation). 
3. General model describing all known mechanisms of miRNA action. This model was 
developed by the authors of this chapter [24,60] and includes nine mechanisms of 
miRNA action. Using this model, we classify the existing mechanisms by their 
dynamical properties and suggest a tool to distinguish most of them based on 
experimental data. 
Of course, any mathematical model is a significant simplification of biological reality. The 
first two models, for example, consider only a limited subset of all possible mechanisms of 
microRNA action on the translation process. All processes of synthesis and degradation of 
mRNA and microRNA are deliberately neglected in these models. Interaction of microRNA 
and mRNA is simplified: it is supposed that the concentration of microRNA is abundant with 
respect to mRNA. Interaction of only one type of microRNA and one type of mRNA is 
considered (not a mix of several microRNAs). The process of initiation is greatly simplified: 
all initiation factors are represented by only one molecule which is marked as eIF4F. 
Finally, the classical chemical kinetics approach is applied, based on solutions of ordinary 
differential equations, which assumes sufficient and well-stirred amount of both microRNAs 
and mRNAs. Another assumption in the modeling is the mass action law assumed for the 
reaction kinetic rates. 
It is important to underline the interpretation of certain chemical species considered in the 
system. The ribosomal subunits and the initiation factors in the model exist in free and bound 
forms. Moreover, the ribosomal subunits can be bound to several regions of mRNA (the 
initiation site, the start codon, the coding part). Importantly, several copies of fully assembled 
ribosomes can be bound to one mRNA. To model this situation, we have to introduce the 
following quantification rule for chemical species: amount of ``ribosome bound to mRNA" 
means the total number of ribosomes translating proteins, which is not equal to the number of 
mRNAs with ribosome sitting on them, since one mRNA can hold several translating 
ribosomes (polyribosome). In this view, mRNAs act as places or catalyzers, where translation 
takes place, whereas mRNA itself formally is not consumed in the process of translation, but, 
of course, can be degraded or synthesized.  
Let us introduce notations that will be used throughout the chapter for designation of chemical 
species: 
1. 40S, free small ribosomal subunit. 
2. 60S, free large ribosomal subunit.  
3. eIF4F, free initiation factor. 
4. M, free mRNA (models 1 and 2) and mRNA with free initiation site (model 3). 
5. P, translated protein. 
6. B, mRNA located in P-bodies. 
7. F, state of mRNA when the small ribosomal subunit bound to the initiation site.  
8. A, state of mRNA when the small ribosomal subunit bound to the start codon.  
9. R, translating ribosome, located on mRNA.  
Square brackets will denote the amounts of the corresponding species. For example, [M] will 
denote the amount of free mRNA in the system.  
Note that the notations for the kinetic rate constants are not equivalent in three models. For 
example, while k1 notifies the kinetic rate of the cap initiation in the models 1 and 2, it has 
different measure units in linear and non-linear models. Moreover, in the model 3, k1 notifies 
the rate constant for translation initiation (recruiting 40S subunit) of mRNA already in 
translation process. Hence, the meaning of ki constants should be considered differently per 
each model type.  
 
4. Simplest linear model of protein translation 
The simplest representation of the translation process has the form of a circular cascade of 
reactions [62] (see Figure 13.2). The model contains four chemical species 40S, F, A and P 
and three chemical reactions. 
The catalytic cycle in which the protein is produced is formed by the following reactions: 
1. 40S → F, Initiation complex assembly (rate k1). 
2. F → A, Some late and cap-independent initiation steps, such as scanning the 5'UTR for the 
start A codon recognition (rate k2) and 60S ribosomal unit joining.  
3. A → 40S, combined processes of protein elongation and termination, which leads to 
production of the protein (rate k3), and fall off of the ribosome from mRNA. 
The model is described by the following system of equations [62]: 
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where Psynth(t) is the rate of protein synthesis. 
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           a)                                                                                      b) 
Figure 13.2. The simplest mathematical model of protein translation which is capable to explain the effect of a 
miRNA on the very early (rate k1) and late (rate k2) steps of mRNA initiation; a) graphical presentation of the 
model in the SBGN standard; b) schematic model presentation. Action of miRNA is modeled by reducing the 
rate constant of the corresponding translation step.  
 
Following [62], let us assume that k3 >> k1, k2. This choice was justified by the following 
statement: ``...The subunit joining and protein production rate (k3) is faster than k1 and k2 
since F complexes bound to the A without the 60S subunit are generally not observed in 
translation initiation unless this step is stalled by experimental methods, and elongation is 
generally thought to not be rate limiting in protein synthesis..." [62]. 
Under this condition, the equations (1) have the following approximate solution (which 
becomes the more exact the smaller the (k1+k2)/k3 ratio), suggested earlier in [90]: 
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From the solution (2-3) it follows that the dynamics of the system evolves on two time scales: 
1) fast elongation dynamics on the time scale ≈1/k3; and 2) relatively slow translation 
initiation dynamics with the relaxation time trel ≈
21
1
kk 
. The protein synthesis rate formula 
(2-3) does not include the k3 rate, since it is neglected with respect to k1, k2 values. From (2-
3) we can extract the formula for the protein synthesis steady-state rate Psynth(t) (multiplier 
before the parentheses) and the relaxation time trel for it (inverse of the exponent power): 
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Now let us consider two experimental situations: 1) the rate constants for the two translation 
initiation steps are comparable k1 ≈ k2, and 2) the cap-dependent rate k1 is limiting: k1 << 
k2. Accordingly to [62], the second situation can correspond to modified mRNA with an 
alternative cap-structure (A-cap), which is much less efficient for the assembly of the 
initiation factors, 40S ribosomal subunit and polyA-binding proteins. 
For these two experimental systems (let us call them “wild-type” and “modified” 
correspondingly), let us study the effect of microRNA action. We will model the microRNA 
action by diminishing the value of a kinetic rate constant for the reaction representing the step 
on which the microRNA is acting. Let us assume that there are two alternative mechanisms: 
1) microRNA acts in a cap-dependent manner (thus, reducing the k1 constant) and 2) 
microRNA acts in a cap-independent manner, for example, through interfering with 60S 
subunit joining (thus, reducing the k2 constant). The dependence of the steady rate of protein 
synthesis Psynth ~ 
2
1
1
1
1
kk

 and the relaxation time trel ≈
21
1
kk 
 on the efficiency of the 
microRNA action (i.e., how much it is capable to diminish a rate coefficient) is shown in 
Figure 13.3. 
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Figure 13.3. Dependence of the relative change of the protein synthesis steady rate and the relaxation time (time 
needed to achieve the steady rate) on the efficiency with which microRNA can act at an early cap-dependent (k1) 
or late cap-independent (k2) rate of translation. Two scenarios are considered: a wild-type one when k1 value is 
similar to k2 and the case of a modified A-cap structure when k1<< k2 even in the absence of miRNA. 
 
 
Interestingly, experiments with cap structure replacement were made and the effect of 
microRNA action on the translation was measured [55.80]. No change in the protein rate 
synthesis after applying microRNA was observed. From this it was concluded that microRNA 
in this system should act through a cap-dependent mechanism (i.e., the normal ``wild-type" 
cap is required for microRNA recruitment). It was argued that this could be a 
misinterpretation [62] since in the “modified” system, cap-dependent translation initiation is a 
rate limiting process (k1 << k2). Hence, even if microRNA acts in the cap-independent 
manner (inhibiting k2), it will have no effect on the final steady state protein synthesis rate. 
This was confirmed by the graph similar to the Figure 13.3a. 
From the analytical solution (2-3) we can further develop this idea and claim that it is possible 
to detect the action of microRNA in the “modified” system if one measures the protein 
synthesis relaxation time: if it significantly increases then microRNA probably acts in the 
cap-independent manner despite the fact that the steady state rate of the protein synthesis does 
not change. This is a simple consequence of the fact that the relaxation time in a cycle of 
biochemical reactions is limited by the second slowest reaction, see [22,90]. If the relaxation 
time does not change in the presence of microRNA then we can conclude that none of the two 
alternative mechanisms of microRNA-based translation repression is activated in the system, 
hence, microRNA action is dependent on the structure of the “wild-type” transcript cap. 
The observations from the Figure 13.3 are recapitulated in the Table 13.1. This analysis (of 
course, over-simplified in many aspects) provides us with an important lesson: observed 
dynamical features of the translation process with and without presence of microRNA can 
give clues on the mechanisms of microRNA action and help to distinguish them in a 
particular experimental situation. Theoretical analysis of the translation dynamics highlights 
the important characteristics of the dynamics which should be measured in order to infer the 
possible microRNA mechanism. 
This conclusion suggests the notion of a kinetic signature of microRNA action mechanism 
which we define as a set of measurable characteristics of the translational machinery 
dynamics (features of time series for protein, mRNA, ribosomal subunits concentrations) and 
the predicted tendencies of their changes as a response to microRNA action through a 
particular biochemical mechanism. 
 
Table 13.1. Modeling two mechanisms of microRNA action on several translation steps in the simplest linear 
model 
Observable value Initiation 
Step after initiation, 
cap-independent 
Elongation 
Wild-type cap 
Steady-state rate of 
protein synthesis 
decreases decreases no change 
Relaxation time of 
protein synthesis 
increases slightly increases slightly no change 
A-cap 
Steady-state rate of 
protein synthesis 
decreases no change no change 
Relaxation time of 
protein synthesis 
no change increases drastically no change 
 
 
 
 
 
5. Non-linear Nissan and Parker’s model of protein translation 
To explain the effect of microRNA interference with translation initiation factors, a non-linear 
version of the translation model was proposed in [62] which explicitly takes into account 
recycling of initiation factors (eIF4F) and ribosomal subunits (40S and 60S). 
 
5.1.  Model equations and the steady state solutions 
The model contains the following list of chemical species (Figure 13.4): 40S, 60S, eIF4F, F, 
A, and R and four reactions, all considered to be irreversible: 
1. 40S + eIF4F → F, assembly of the initiation complex (rate k1). 
2. F → A, some late and cap-independent initiation steps, such as scanning the 5'UTR for the 
start codon A (rate k2). 
3. A → R, assembly of ribosomes and protein translation (rate k3). 
4. 80S → 60S+40S, recycling of ribosomal subunits (rate k4). 
The model is described by the following system of equations [62]: 
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The model (5) contains three independent conservations laws: 
   [F] + [40S] + [A] + [R] = [40S]0, 
   [F] + [eIF4F] = [eIF4F]0,        (6) 
   [60S] + [R] = [60S]0, 
where [40S]0, [60S]0 and [eIF4F]0 are total amounts of available small, big ribosomal subunits 
and the initiation factor respectively. 
The following assumptions on the model parameters were suggested [62]: 
k4<< k1,k2,k3, 
k3>> k1,k2, 
[eIF4F]0<<[40S]0,         (7) 
[eIF4F]0 < [60S]0 < [40S]0, 
with the following justification: ``...The amount 40S ribosomal subunit was set arbitrarily 
high ... as it is thought to generally not be a limiting factor for translation initiation. In 
contrast, the level of eIF4F, as the canonical limiting factor, was set significantly lower so 
translation would be dependent on its concentration as observed experimentally... Finally, the 
amount of subunit joining factors for the 60S large ribosomal subunit were estimated to be 
more abundant than eIF4F but still substoichiometric when compared to 40S levels, consistent 
with in vivo levels... The k4 rate is relatively slower than the other rates in the model; 
nevertheless, the simulation's overall protein production was not altered by changes of several 
orders of magnitude around its value..." [62]. 
 
 
40S
F A
Protein
k1
k2
k4
miRNA
cap-dependent
eIF4F miRNA
cap-independent
80S
60S
k3
k3 >> k1,k2
k4 << k1,k2,k3
40S0 >> eIF4F0
eIF4F0 < 60S0 < 40S0
miRNA
60S joining
miRNA
Elongation  
                                 a)                                                                     b)       
Figure 13.4. The mathematical model of protein translation which explicitly takes into account recycling of 
ribosomes and initiation factors; a) graphical presentation of the model in the SBGN standard; b) schematic 
model presentation. 
 
The last statement about the value of k4 is needed to be made more precise: in the model by 
Nissan and Parker, k4 is a sensitive control parameter. It does not affect the steady state 
protein synthesis rate only in one of the possible scenarios (inefficient initiation, deficit of the 
initiation factors, see below). 
The final steady state of the system can be calculated from the conservation laws and the 
balance equations among all the reaction fluxes: 
 
    k2[F]s = k3[A]s [60S]s =k4[R]s = k1[40S]s [eIF4F]s     (8) 
 
where “s” index stands for the steady state value. Let us designate a fraction of the free [60S] 
ribosomal subunit in the steady state as 
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and the equation to determine x, in which we have neglected the terms of smaller order of 
magnitude, based on conditions (7): 
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From the inequalities on the parameters of the model, we have >1, <<1 and, if 
k1>> k4/[eIF4F]0 then <<. From these remarks it follows that the constant term (1-) of 
the equation (10) should be much smaller than the other polynomial coefficients, and the 
equation (10) should have one solution close to zero and two others: 
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provided that <<|1-| or <<|1-|. In the expression for x1 we cannot neglect the term 
proportional to , to avoid zero values in (10). 
The solution x2 is always negative, which means that one can have one positive solution 
x0<<1,  if 1
]60[4
]4[2
0
0 
Sk
FeIFk , and two positive solutions x0 and x1 , if 1
]60[4
]4[2
0
0 
Sk
FeIFk . However, it 
is easy to check that if x1 > 0 then x0 does not correspond to a positive value of [eIF4F]s. This 
means that for a given combination of parameters satisfying (7) we can have only one steady 
state (either x0 or x1). 
The two values x = x0 and x = x1 correspond to two different modes of translation. When, 
for example, the amount of the initiation factors [eIF4F]0 is not enough to provide efficient 
initiation (
0
0 ]60[4
2
]4[
Sk
k
FeIF  , x = x1) then most of the 40S and 60S subunits remain in the 
free form, the initiation factor eIF4F being always the limiting factor. If the initiation is 
efficient enough (
0
0 ]60[4
2
]4[
Sk
k
FeIF  ), then we have x = x0<<1 when almost all 60S 
ribosomal subunits are engaged in the protein elongation, and [eIF4F] being a limiting factor 
at the early stage. However, it is liberated after and ribosomal subunits recycling becomes 
limiting in the initiation (see the next section for the analysis of the dynamics). 
Let us notice that the steady state protein synthesis rate under these assumptions is 
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This explains the numerical results obtained in [62]: with low concentrations of [eIF4F]0 
microRNA action would be efficient only if it affects k2 or if it competes with eIF4F for 
binding to the mRNA cap structure (thus, effectively further reducing the level [eIF4F]0). 
With higher concentrations of [eIF4F]0, other limiting factors become dominant: [60S]0 
(availability of the heavy ribosomal subunit) and k4 (speed of ribosomal subunits recycling 
which is the slowest reaction rate in the system). Interestingly, in any situation the protein 
translation rate does not depend on the value of k1 directly (of course, unless it does not 
become “globally” rate limiting), but only through competing with eIF4F (which makes the 
difference with the simplest linear protein translation model). 
Equation (12) explains also some experimental results reported in [55]: increasing the 
concentration of [eIF4F] translation initiation factor enhances protein synthesis but its effect 
is abruptly saturated above a certain level. 
 
5.2. Analysis of the model dynamics 
It was proposed to use the following model parameters: k1=k2=2, k3=5, k4=1, [40S]0=100, 
[60S]0=25, [eIF4F]0=6 [62]. As we have shown in the previous section, there are two 
scenarios of translation possible in the Nissan and Parker's model which we called “efficient” 
and “inefficient” initiation. The choice between these two scenarios is determined by the 
combination of parameters
0
0
]60[4
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 . For the original parameters from [62],  = 0.48 < 1 
and this corresponds to the simple one-stage “inefficient” initiation scenario. To illustrate the 
alternative situation, we changed the value of k4 parameter, putting it to 0.1, which makes  = 
4.8 > 1. The latter case corresponds to the “efficient” initiation scenario, the dynamics is more 
complex and goes in three stages (see below). 
Simulations of the protein translation model with these parameters and the initial conditions 
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are shown in Figure 13.5. The system shows non-trivial relaxation process which takes place 
in several epochs. Qualitatively we can distinguish the following stages: 
1) Stage 1: Relatively fast relaxation with conditions [40S]>>[eIF4F], [60S]>>[A]. 
During this stage, the two non-linear reactions 40S+eIF4F → F and A+60S → R can be 
considered as pseudo-monomolecular ones: eIF4F → F and A → R with rate constants 
dependent on [40S] and [60S] respectively. This stage is characterized by rapidly establishing 
quasiequilibrium of three first reactions (R1, R2 and R3 with k1, k2 and k3 constants). 
Biologically, this stage corresponds to the assembling of the translation initiation machinery, 
scanning for the start codon and assembly of the first full ribosome at the start codon position. 
2) Transition between Stage 1 and Stage 2. 
3) Stage 2: Relaxation with the conditions [40S]>> [eIF4F], [60S]<< [A]. During this 
stage, the reactions 40S+eIF4F → F and A+60S → R can be considered as pseudo-
monomolecular eIF4F → F and 60S → 80S. This stage is characterized by two local quasi-
steady states established in the two network reaction cycles (formed from R1-R2 and R3-R4 
reactions). Biologically, this stage corresponds to the first round of elongation, when first 
ribosomes move along the coding region of mRNA. The small ribosomal subunit 40S is still 
in excess which keeps the initiation stage (reaction R1-R2 fluxes) relatively fast. 
4) Transition between Stage 2 and Stage 3. 
5) Stage 3: Relaxation with the conditions [40S]<< [eIF4F], [60S]<< [A]. During this 
stage, the reactions 40S+eIF4F → F and A+60S → R can be considered as pseudo-
monomolecular 40S → F and 60S → R. During this stage all reaction fluxes are balanced. 
Biologically, this stage corresponds to the stable production of the protein with constant 
recycling of the ribosomal subunits. Most of ribosomal subunits 40S are involved in protein 
elongation, so the initiation process should wait the end of elongation for that they would be 
recycled. 
Our analysis of the non-linear Nissan and Parker's model showed that the protein translation 
machinery can function in two qualitatively different modes, determined by the ratio 
0
0
]60[4
]4[2
Sk
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 [90]. We call these two modes “efficient initiation” (>1) and “inefficient 
initiation” (<1) scenarios. Very roughly, this ratio determines the balance between the 
overall speeds of initiation and elongation processes. In the case of “efficient initiation” the 
rate of protein synthesis is limited by the speed of recycling of the ribosomal components 
(60S). In the case of “inefficient initiation” the rate of protein synthesis is limited by the speed 
of recycling of the initiation factors (eIF4F). Switching between two modes of translation can 
be achieved by changing the availability of the corresponding molecules ( [60S]0 or [eIF4F]0 ) 
or by changing the sensitive kinetic parameters (k2 or k4). 
 
 
 
Figure 13.5. Numerical simulations of the species concentrations and fluxes of the non-linear translation model. 
a) and c) log-log scale; b) and d) log-scale in values, and linear scale for the time axis (the time units are 
arbitrary, since the dimensionality of the parameters in [62] was not specified). 
 
As a result of the dynamical analysis, we assembled an approximate solution of the non-linear 
system under assumptions (7) about the parameters. The detailed description of this solution 
is given in [90]. The advantage of such a semi-analytical solution is that one can predict the 
effect of changing the system parameters.  
One of the obvious predictions is that the dynamics of the system is not sensitive to variations 
of k3, so if microRNA acts on the translation stage controlled by k3 then no microRNA effect 
could be observed looking at the system dynamics (being the fastest one, k3 is not a sensitive 
parameter in any scenario). 
If microRNA acts on the translation stage controlled by k4 (for example, by ribosome stalling 
mechanism) then we should consider two cases of efficient (>1) and inefficient ( <1) 
initiation. In the first case the steady state protein synthesis rate is controlled by k4 (as the 
slowest, limiting step) and any effect on k4 would lead to the proportional change in the 
steady state of protein production. By contrast, in the case of inefficient initiation, the steady 
state protein synthesis is not affected by k4. Instead, the relaxation time is affected, 
being
4
1
~
k
. However, diminishing k4 increases the  parameter: hence, this changes 
“inefficient initiation” scenario for the opposite, making k4 sensitive for the steady state 
protein synthesis anyway, when k4 becomes smaller than 
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0
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. For example, for the 
default parameters of the model, decreasing k4 value firstly leads to no change in the steady 
state rate of protein synthesis, whereas the relaxation time increases and, secondly, after the 
threshold value 
0
0
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 starts to affect the steady state protein synthesis rate directly. This 
is in contradiction to the message from [62] that the change in k4 by several orders of 
magnitude does not change the steady state rate of protein synthesis. 
Analogously, decreasing the value of k2 can convert the “efficient” initiation scenario into the 
opposite after the threshold value 
0
0
]4[
]60[4
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Sk
. We can recapitulate the effect of decreasing k2 in 
the following way: 1) in the case of the “efficient” initiation k2 does not affect the steady state 
protein synthesis rate up to the threshold value after which it affects it in a linear manner. The 
relaxation time drastically increases, because decreasing k2 leads to elongation of all 
dynamical stages duration (for example, we have estimated the time of the end of the 
dynamical Stage 2 as 
0
0
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'''
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S
t  . However, after the threshold value the relaxation time 
decreases together with k2, quickly dropping to its unperturbed value; 2) in the case of 
“inefficient” initiation the steady state protein synthesis rate depends proportionally on the 
value of k2 (12), while the relaxation time is not affected. 
 
 
Table 13.2. Modeling of four mechanisms of microRNA action in the non-linear protein translation model 
Observable value Initiation 
Step after 
initiation 
Ribosome 
assembly 
Elongation 
Wild-type cap, inefficient initiation 
Steady-state rate slightly decreases decreases no change 
decreases after 
threshold 
Relaxation time no change no change no change goes up and down 
Wild-type cap, efficient initiation 
Steady-state rate no change 
slightly decreases 
after strong 
inhibition 
no change decreases 
Relaxation time no change goes up and down no change no change 
A-cap, inefficient initiation 
Steady-state rate decreases decreases no change 
slightly decreases 
after strong 
inhibition 
Relaxation time no change no change no change goes up and down 
A-cap, efficient initiation 
Steady-state rate 
decreases after 
threshold 
slightly decreases 
after strong 
inhibition 
no change decreases 
Relaxation time goes up and down goes up and down no change increases 
 
MicroRNA action on k1 directly does not produce any strong effect neither on the relaxation 
time nor on the steady state protein synthesis rate. This is why in the original work [62] cap-
dependent mechanism of microRNA action was taken into account through effective change 
of the [eIF4F]0 value (total concentration of the translation initiation factors), which is a 
sensitive parameter of the model (5). 
The effect of microRNA through various mechanisms and in various experimental settings 
(excess or deficit of eIF4F, normal cap or A-cap) is recapitulated in Table 13.2. The 
conclusion that can be made from this table is that all four mechanisms show clearly different 
patterns of behavior in various experimental settings. From the simulations one can make a 
conclusion that it is still not possible to distinguish between the situation when microRNA 
does not have any effect on protein translation and the situation when it acts on the step which 
is neither rate limiting nor “second rate limiting” in any experimental setting (k3 in our case). 
Nevertheless, if any change in the steady-state protein synthesis or the relaxation time is 
observed, theoretically, it is possible to specify the mechanism responsible for it. 
 
6. General model of miRNA-mediated translation regulation 
Nine distinct mechanisms of microRNA action have been described in the literature: the main 
experimental data supporting each proposed mechanism are summarized in the review section 
of this chapter. The complete model containing all known microRNA action mechanisms is 
shown in Figure 13.6a using an SBGN standard diagram.  
The principal differences between the Nissan and Parker’s model and the model described in 
this section are 1) the complete model describes all nine known mechanisms of miRNA 
action; 2) mRNA amount is a dynamical variable, i.e. it is modelled explicitly, taking into 
account its synthesis and degradation; 3) we explicitly model binding of miRNA at various 
stages of translation, i.e. in our model both mRNA in free and miRNA-bound forms are 
present; 4) we assume concentration of eIF4F and ribosomal subunits present in excess, as in 
the simplest model. 
For modelling, we assumed that the initiation factors and ribosomal subunits are always 
available in excess. This allowed us to simplify the model to 12 chemical species and 20 
reactions, as described below and schematically shown in Figure 13.6b: 
[M0] – new synthesized and not yet initiated mRNA 
[F0] – new initiated mRNA, with initiation complex, including 40S ribosomal subunit 
[M] – initiated mRNA with free translation initiation site  
[F] – initiated mRNA with translation initiation site occupied by 40S ribosomal subunit   
[R] – number of ribosomes fully assembled on miRNA-free mRNA 
[M'0] – new synthesized not initiated mRNA with one or more miRNAs bound 
[F'0] – new mRNA with initiation complex, including 40S ribosomal subunit,  with 
miRNA(s) bound to mRNA 
[M'] – initiated miRNA-bound mRNA with free translation initiation site 
[F'] – initiated miRNA-bound mRNA with translation initiation site occupied by 40S 
ribosomal subunit  
[R'] – ribosomes fully assembled on miRNA-bound mRNA  
[P] – protein, completely translated from the given mRNA 
[B] – mRNA sequestered in P bodies. 
  
Let us make a notice on interpretation of some of the model variables. Explicit description of 
mRNA:ribosome complexes would require separate dynamical variables for the amounts of 
mRNA with one ribosome, mRNA with two ribosomes, mRNA with three ribosomes, and so 
on (potentially, large number of variables). To avoid this complexity, we apply lumping of the 
detailed model, described in [24]. In the lumped reaction network, new produced mRNA 
(state M0) is first initiated and prepared for the first round of translation (state F0). After that, 
the initiated mRNA alternates between states M (state ready for the next round of translation) 
and F (mRNA prepared for the next ribosome assembly). During each such a round, a new 
assembled ribosomal complex (R) appears in the system. Thus, we explicitly separate the 
process of mRNA initiation (which can include capping, adenylylation, circularization, 
mRNA transport to specific cellular regions) and the process of recruiting 40S ribosomal 
subunit at already initiated mRNA for the next round of translation. In our model, these two 
processes proceed with different speeds. 
In our interpretation, we consider mRNAs as places for a catalytic reaction (protein 
translation). These places (amount of catalyzer) in our model can be synthesized or destroyed 
and present in four states (non-initiated, initiated, in ‘translating’ state ready for assembling 
new ribosome and in ‘translating’ state with a new assembling ribosome). To take into 
account miRNA, we say that there are two types of catalyzer: miRNA-free and miRNA-
bounded, with different rate constants of degradation. miRNA-free catalyzer can be 
irreversibly transformed into miRNA-bounded type of catalyzer. 
Importantly, [R] in our interpretation is not the amount of mRNA translating proteins but the 
amount of ribosomes bound to mRNA and translating proteins, i.e. the number of sites where 
the catalysis takes place. Dividing the number of these sites on the amount of the catalyzer in 
the initiated state [M]+[F] gives the average number of ribosomes per translating mRNA, 
which we denote as [RB].  
The definition of the kinetic rate constants used further in the paper is the following: 
1. null → M0, the free mRNA is transcribed in the system with the rate constant kt. 
2. M0 → F0, assembly of initiation complex and 40S ribosomal subunit with mRNA occurs 
with the rate constant k01 
3. F0 → M+R, assembly of the first ribosome on the initiation site with the rate constant k2 
4. M → F, initiation of the translation (recruitment of 40S subunit) on already translated 
mRNA, with the rate constant k1 
5. F → M+R, assembly of full ribosome (S80) on mRNA occurs with the rate constant k2 
6. R → P, translation of the protein with consequent release of ribosomes occurs with the rate 
constant k3 
7. R → null, degradation of mRNA leads to release of ribosomes with the rate constant kd , 
same reaction describes premature ribosome drop-off from mRNA with the rate constant krd 
We will assume that the process of microRNA binding to mRNA can occur at various stages 
of translation and that its rate kb will be the same in each of the following reactions: 
8. M0 → M0' 
9. F0 → F0' 
10. M → M' 
11. F → F' 
12. R → R' 
In the same way we will assume that the rate of degradation of mRNA not driven by 
microRNA action (kd) can be considered as the same one at all stages of translation: 
13. M0 → null 
14. F0 → null 
13. M → null 
14. F → null 
The degradation rate of mRNA bound to microRNA could occur with or without direct action 
of microRNA on its degradation. For the beginning we will assume that this rate constant (kd') 
is different from the free mRNA degradation and it is the same one for all stages of 
translation: 
15. M'0 → null 
16. F'0 → null 
17. M' → null 
18. F' → null 
19. R' → null 
Next we assume that the reaction corresponding to the assembly of the initiation complex and 
40S ribosomal subunit with mRNA in the presence of miRNA (M'0 → F'0) will occur with the 
rate constant k01'. 
20. M'0 → F'0 
Recruitment of 40S subunit on already translating miRNA-bound mRNA occurs with the rate 
constant k1': 
21. M' → F' 
Reactions of assembly of the full ribosome (S80) on mRNA in the presence of microRNA 
occur with the rate constant k2': 
22. F'0 → M'+R 
23. F' → M'+R 
The rate of protein production in the case of microRNA action is described by the following 
reaction: 
24. R' → P, with the rate constant k3' 
25. R' → null, describes possible mechanism of ribosomal drop-off (without protein 
production), with the rate constant krd', and mRNA degradation with ribosome release, with 
the rate constant kd'. 
Reactions 26 and 27 describe the reverse process of mRNA sequestration in P-bodies, with 
rates k+s and k-s correspondingly: 
26. M0' → B,  
27. B → M0' 
The mRNA in P-bodies is degraded with specific rate kbd' 
28. B → null 
29. P + R’ → null, the rate of protein degradation by microRNA-independent mechanisms is 
kp , while it can be increased in the presence of miRNA by kr×R’. 
The system of equations dx/dt = K0+Kx (where x is the vector of 12 dynamic variables, K is 
the kinetic matrix, and K0 is the vector of production with only one non-zero component 
corresponding to the transcriptional synthesis of mRNA) has the following form: 
Thus, for this simplified linear model we need to define the proper values for 18 coefficients 
corresponding to the rates of reactions. 
For simulations, we needed the numerical values of 18 kinetic coefficients, which were 
estimated from published reports and are provided in Table 13.3. Although it is obvious that 
all rates diverge considerably for different mRNAs, experimental data mining allowed us to 
make a plausible assumption for almost all of the kinetic rates used in the model. For 
example, mRNA half-lives vary from a few minutes to more than 24 h, with a mean at 10 h 
[88], which we selected as the corresponding rate. It is nevertheless possible that highly 
regulated mRNAs, such as most miRNA targets, have shorter half-lives. The same reasoning 
also applies to protein half-lives. 
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Similarly, we estimated the elongation time for mRNA translation as 1-2 min [7,30,76], even 
though it depends on the mRNA length: at 10 aa/sec [20], 1-2 min corresponds to a mean 
length of 1.8 to 3.6 kb [26]. Likewise, the numbers of ribosomes per mRNA molecule are 
highly variable, from 4-5 to more than 10 [7,54]. We considered 6 ribosomes per mRNA as 
being a reasonable assumption. We therefore postulated that 6 initiation events occur during a 
cycle of elongation, which leads to an estimate of 6 initiations/minute, and is of the same 
order of magnitude as what has been proposed previously [7]. All information concerning the 
kinetic coefficients we used for our modelling is summarized in Table 13.3. 
 
 
 
 
7. Distinct dynamical types of miRNA action and kinetic signatures of miRNA 
mechanisms 
 
7.1. Analytical solution of model equations for the case of normal  
translation (no miRNA) 
 
The dynamical variables that can be observed and measured in the experiment are 
Total amount of mRNA:   MT = M0+F0+M+F+M0’+F0’+M’+F’+B 
Total amount of protein:   PR = P 
Average number of ribosomes, 
translating one mRNA:   RB = (R+R’)/( M+M’+F+F’) 
 
The solution of model equations and expression for [MT], [PR], [RB] for the trivial case without 
miRNA in the system were obtained. This can be modelled by putting to zero the binding constant 
kb = 0.  
For this case the steady state values for the measurable quantities are 
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and the relaxation times are 
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where we have assumed that k1 >> k01, k2, k3.   
These formulas allow qualitative understanding of the effect of miRNA on various steps of 
translation and the corresponding kinetic signatures. They can also help to decipher 
experimentally observed kinetic signatures when multiple mechanisms are present 
simultaneously and the translation parameters are not known. Exact recipe on doing this will 
be a subject of our future work. 
 
7.2. Dominant paths of the model and their relations to the miRNA mechanisms 
According to the methodology of asymptotology [23], let us consider the case of well 
separated constants, i.e. when any two kinetic constants in the graph in the Figure 13.6b have 
different orders of magnitude at each fork (i.e., a node with several outgoing reactions). Each 
such a (partial) ordering of kinetic constants will generate a path on the graph (possibly, 
cyclic), starting at M0 node. We will call it the dominant path. Each path corresponds to one 
(if it does not contain cycles) or several (if it contains a cycle) dominant systems and to a 
distinguishable biochemical scenario. For example, the partial ordering (kb >> k1, kd ; k’01 >> 
k-s, k’d ; k’2 << k’d) corresponds to the dominant path describing the process of translation 
inhibition via 60S subunit joining repression (see Table 13.4, path M0M’0F’0). 
A dominant path is connected to a dominant system (whose solution of the corresponding 
dynamics equations provides an asymptotic approximation of the whole system dynamics) in 
the following way. If the path does not contain cycles, then it represents the dominant system. 
If the path contains cycles then the cycles should be glued and represented by single nodes 
(which will represent quasistationary distribution of chemical species concentrations inside 
the cycle). Then one should find the dominant path for the new graph with glued cycles and 
continue until an acyclic dominant path will be found. Depending on the ordering of kinetic 
rates inside each cycle, one cyclic dominant path can lead to several different dominant 
systems. The dominant system in general represents a hierarchy of glued cycles. The details 
of constructing dominant systems are provided in [22,72]. 
 
 
Figure 13.6. Mathematical model taking into account all nine mechanisms of miRNA action; a) graphical 
presentation of the model in the SBGN standard; b) schematic model presentation in the assumption that 
ribosomal subunits and initiation factors are present in excess. 
 
It is convenient to designate each dominant path by nodes through which it passes. There are 
many possible reaction graph traversals leading to multiple possible dominant paths, if one 
considers all partial orderings of the constants in the reaction forks.  However, some of them 
are biologically non-relevant. For example, the ordering kd >> k01 (dominant path M0) will not 
lead to any translation (the mRNA will be degraded before it will be initiated). In the same 
way, kd >> k2 (dominant path M0F0) will terminate the normal translation prematurely. Thus, 
we postulate kd << k01, k2, k3.  Also for simplicity we assume that binding of miRNA to mRNA 
is more rapid than normal initiation, i.e., kb >> k01, k2, k3 if there is miRNA in the system, and 
kb = 0, if not. Also we assume that k01 << k1, because k1 corresponds to recruiting 40S subunit 
on already initiated and translated mRNA (which we assume never be rate-limiting), while k01 
includes both mRNA initiation and 40S subunit recruiting. This leads to 6 biologically 
relevant dominant paths, all of which are listed in Table 13.4.  
 
Table 13.3. Reference set of parameters for the model and their changes according to the action of various 
miRNA-mediated mechanisms of translation repression 
Kinetic 
rate 
constant 
Reference 
value or 
interval 
Comment 
Parameters of transcription and translation without miRNA action 
kt 10
-3  Transcription kinetic rate. If Transcriptional Inhibition mechanism is active 
then this constant is proportionally reduced from kt (0% efficiency of the 
mechanism) to zero (100% efficiency of the mechanism). 
k01 210-4 mRNA early initiation rate in the absence of miRNA.  
k1 1 rate of 40S recruitement at already translated mRNA, considered to be fast and 
not rate-limiting 
k2 610-2 60S unit joining and assembly of the full ribosome on mRNA rate in the absence of 
miRNA. 
k3 10
-2 Rate including elongation and termination of translation in the absence of 
miRNA. In all simulations of translation without miRNA, we assume that k3= k3/6, 
which gives 6 ribosomes sitting on one translated mRNA in average. 
kd 10
-5 mRNA degradation rate in the absence of miRNA. In all simulations of translation 
without miRNA, we assume that kd << k1, k2, k3. Otherwise mRNA will be 
degraded much faster than it will be initiated and translated. 
krd 0 Rate of ribosome drop-off. We neglect the ribosome drop-off in the absence of 
miRNA 
kp 510-6 Rate of protein degradation in the absence of miRNA. 
Parameters of various mechanisms of miRNA action 
kb 10
-3 (strong) 
10-4  (medium) 
10-5  (weak) 
Rate of miRNA binding to mRNA. This rate depends on many factors including the 
complementarity of miRNA sequence to the sequence of the binding site. We 
assume that depending on these factors, the rate can vary in the range of several 
orders of magnitude. When kb <<min(k1, k2, k3), we consider the binding as weak, 
because it does not considerably influence the rate of translation. 
k01
’ [0; k01] mRNA initiation rate with miRNA. If Cap Inhibition mechanism is active then 
this constant can be proportionally reduced from k1 to zero. 
k1
’ k01 40S recruitement at already translated miRNA-bound mRNA, we do not consider 
the corresponding hypothetical mechanism in the model 
k2
’ [0; k2] 60S unit joining and assembly of the full ribosome on mRNA rate with miRNA. If 
60S Unit Joining Inhibition mechanism is active then this constant can be 
proportionally reduced from k2 to zero. 
k3
’ [0; k3] Rate including elongation and termination of translation with miRNA. If 
Elongation Inhibition mechanism is active then this constant can be 
proportionally reduced from k3 to zero. 
kd
’ [kd; 10
2kd] Rate of mRNA degradation with miRNA. If Decay mechanism is active then this 
constant can increase 10-fold at 100% mechanism efficiency. If Cleavage 
mechanism is active then this constant can increase by 100-fold.   
k±s [0; 510-2] Rate of reversible capturing of mRNA to P-bodies. If P-bodies Sequestration 
mechanism is active, this constant can be proportionally increased from zero to 
k+s. The reverse rate constant k-s is assumed to be k-s = 5k+s. We assume that 
mRNA can be degraded in P-bodies with the rate kd
’. 
k’rd [0; 5k3
’] Rate of ribosome drop-off. If Ribosome Drop-Off mechanism is active then this 
constant is proportionally increased from 0 to 5k3
’. 
kr [0; 510-5] Rate of co-translational protein degradation catalysis. If Co-Translational 
Protein Degradation mechanism is active then this constant is proportionally 
increased from zero to 510-5, and the protein degradation rate is increased as 
kp
miRNA = kp+ krR’. 
 
 
Table 13.4 shows that the types of dynamical behavior (dominant paths) can be mapped onto 
the biologically characterized mechanisms of miRNA action, but this mapping is not one-to-
one: several biological mechanisms can correspond to one dynamical type (for example, 
M0M’0 dominant path corresponds to M1, M7 and M8 biological mechanisms and, 
conversely, biological mechanism M1 can correspond to M0M’0 or M0M’0F’0M’F’R’P 
dominant paths). 
 
7.3. Kinetic signatures of miRNA-mediated mechanisms of protein translation inhibition 
In order to provide a practical recipe to distinguish between nine different mechanisms of 
miRNA action, we studied the dynamical behaviour of the model for the reference set of 
parameters for weak, medium and strong miRNA binding strengths. The simulation was 
performed in the following way: 
1) First, the system was simulated from zero initial conditions without presence of 
miRNA (kb = 0) in the time interval [0; 20/kd]. The steady state and relaxation time 
values for MT, RB and PR values were estimated from the simulation.  
2) The miRNA binding constant was changed to the corresponding value and the 
simulation was continued from the steady state obtained before in the time interval 
[20/kd; 40/kd]. New steady state and relaxation time values were estimated from the 
simulation. 
The model includes a vector of parameters P={kt, k01, k1, k2, k3, kd, kp} and of mechanism 
strength spectrum S={s1,s2,…,s9} (see the next section), which can vary. Each computational 
experiment is defined by the corresponding vectors P and S, binding constant for miRNA (kb) 
the rest of the model parameters is computed using the following formulas: 
M1 (Cap Inhibition):     k01
’:= (1-s1)k01, 
M2 (60S Unit Joining Inhibition):   k2
’:=(1-s2)k2, 
M3 (Elongation Inhibition):    k3
’:= (1-s3)k3, 
M4 (Ribosome Drop-Off):    krd:= 5s4k3
’, 
M5 (Co-translational protein degradation):  kr:=s5 kr
(ref). 
M6 (Sequestration in P-bodies):   k+s:= 5s6ks
(ref),  k-s= s6  ks
(ref), 
M7 (Decay of mRNA):    kd
’:= (1+9s7)kd, 
M8 (Cleavage of mRNA):    kd
’:= (1+99s8)kd, kb:= (1+99s8)kb  
M9 (Transcriptional Inhibition):   kt:= (1-s9)kt, 
 
The result of the simulation is a kinetic signature for a mixed mechanism of miRNA action, 
characterized by six numbers: relative changes of the steady states 
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PR   and relative changes of relaxation times 
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RT
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RT
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PR  . For the further analysis, using 
Principal Component Analysis (PCA) we use the logarithms of these ratios. 
First, we considered only “pure” mechanisms acting at the maximum 100% efficiency (which 
leads, for example, for a complete block of mRNA elongation in the presence of miRNA, for 
Elongation Inhibition mechanism). The resulting signatures are shown in Figure 13.7.  
Several conclusions can be made from it.  
Firstly, the signatures of nine mechanisms are qualitatively different, i.e. they can be reliably 
distinguished in principle, if the 6 required numbers would be estimated experimentally.  
Secondly, not all mechanisms can be distinguished only based on the steady-state value 
analysis, in accordance with the results of modelling described in the previous sections. Some 
of the relaxation time relative changes should be measured as well in order to distinguish, for 
example, Ribosome Drop-Off from 60S Unit Joining Inhibition.  
Thirdly, one can observe that some of the signature components strongly depend in the 
quantitative fashion on the order of the miRNA binding constant, and some are completely 
insensitive. This suggest an experiment in which several sequences of miRNA would be 
utilised having different (weak, medium, tight) affinities to the target mRNA binding site. 
Observing how the dynamics of observable quantities are changing with the binding affinity, 
one can distinguish the mechanisms more reliably. For example, in the case of Ribosome 
Drop-Off the ribosomal profile should be more sensitive to changing miRNA affinity 
compared to 60S Unit Joining. 
 
8. Coexistence of multiple mechanisms of miRNA action 
One of the most debated questions on the action of miRNA on translation is the possibility of 
co-existence of several mechanisms of miRNA action. Let us study formally to what 
consequences it can lead from the point of view of translation dynamics and kinetic 
signatures. 
We formalize co-existence of several miRNA action mechanisms in the following way. We 
characterized a situation when a miRNA can interfere with several steps of translation (and 
transcription) by a strength spectrum of 9 “pure” mechanisms. The spectrum is a 9-
dimensional vector S={s1,s2,…,s9} with components corresponding to the strengths 
(contributions) of “pure” mechanisms M1, M2,…, M9. Each strength si of this vector can vary 
from 0.0 (absence of the mechanism) to 1.0 (or 100%, maximum strength of the mechanism). 
We call this situation a “combined” mechanism of miRNA action. In this sense, the “pure” 
mechanisms acting at maximum strength (1.0) are basis vectors in the space of “combined” 
mechanisms. For example, the spectrum S={0,1.0,0,0,0,0,0,0,0} corresponds to the blockage 
of 60S unit joining by miRNA without affecting any other step of translation, while 
S={0.8,0,0,0.5,0,0,0,0,0} corresponds to co-existence of Cap Inhibition (at 80% of its 
maximal strength) and Ribosome drop-off (at 50% of its maximal strength). Also  there are 7 
normal translation parameters (without miRNA) kt, k01, k1, k2, k3, kd, kp, which  allow to 
consider a vector of parameters P={kt, k01, k1, k2, k3, kd, kp} in 7–dimensional space of 
parameters. 
In this section we make two computational experiments in which we exhaustively study the 
effect of 1) varying S given P fixed at reference parameters; and 2) varying P given S, for four 
mostly referenced mechanisms: Cap Inhibition, 60S Unit Joining Inhibition, Elongation 
Inhibition, Decay. In other words, in the first case we study the effect of co-existence of 
various mechanisms for a given experimental system, characterized by a given set of normal 
translation parameters. In the second case, we study the effect of variable experimental (or 
cellular) conditions on the conclusions one can make for the same mixed mechanism of 
miRNA action. Thus, the results of this section generalize the results of the previous sections 
to the case of co-existence of several mechanisms at the same time. 
 
 
  
Table 13.4. Dominant paths of the unified model of microRNA action mechanisms 
Dominant path 
Biological 
interpretation 
Corresponding 
miRNA-mediated 
translation 
repression 
mechanism(s) 
M F R P
kT k1 k2
kd kd
kpk3
F0M0
kdkd
k01
k2
kd+krd
M’ F’ R’
k’1 k’2
k’d k’d
k’3
F’0M’0
k’dk’d
k’01 k’2
k’d+k’rd
B
k-s
k+skbd
kb kb kb kb kb
  
M0F0MFRP 
normal translation 
with negligible effect 
of miRNA 
None 
M F R P
kT k1 k2
kd kd
kpk3
F0M0
kdkd
k01
k2
M’ F’ R’
k’1 k’2
k’d k’d
k’3
F’0M’0
k’dk’d
k’01 k’2B
k-s
k+skbd
kb kb kb kb kb
kd+krd
k’d+k’rd
 
M0M’0 
the dominant effect is 
degradation of 
mRNA by miRNA 
M1: Cap inhibition 
M7: Decay 
M8: Cleavage 
M F R P
kT k1 k2
kd kd
kpk3
F0M0
kdkd
k01
k2
M’ F’ R’
k’1 k’2
k’d k’d
k’3
F’0M’0
k’dk’d
k’01 k’2B
k-s
k+skbd
kb kb kb kb kb
kd+krd
k’d+k’rd
 
M0M’0B 
mRNA is captured in 
P-bodies 
M6: Sequestration of 
mRNA in P-Bodies 
M F R P
kT k1 k2
kd kd
kpk3
F0M0
kdkd
k01
k2
M’ F’ R’
k’1 k’2
k’d k’d
k’3
F’0M’0
k’dk’d
k’01 k’2B
k-s
k+skbd
kb kb kb kb kb
kd+krd
k’d+k’rd
 
M0M’0F’0 
mRNA translation is 
stuck after initiation, 
before the assembly 
of the ribosome 
M2: 60S subunit 
joining inhibition 
M F R P
kT k1 k2
kd kd
kpk3
F0M0
kdkd
k01
k2
M’ F’ R’
k’1 k’2
k’d k’d
k’3
F’0M’0
k’dk’d
k’01 k’2B
k-s
k+skbd
kb kb kb kb kb
kd+krd
k’d+k’rd
 
M0M’0F’0M’F’R’ 
mRNA is stuck with 
ribosomes on it and 
destroyed, or mRNA 
translation is 
prematurely aborted 
M3: Elongation 
inhibition 
M4: Ribosome drop-
off 
M F R P
kT k1 k2
kd kd
kpk3
F0M0
kdkd
k01
k2
M’ F’ R’
k’1 k’2
k’d k’d
k’3
F’0M’0
k’dk’d
k’01 k’2B
k-s
k+skbd
kb kb kb kb kb
kd+krd
k’d+k’rd
  
M0M’0F’0M’F’R’P 
protein synthesis in 
the presence of 
miRNA with low 
mRNA degradation 
M1: Cap inhibition 
M2: 60S subunit 
joining inhibition 
M3: Elongation 
inhibition 
M5: Co-translational 
protein degradation 
mechanisms 
 
 
 
  
Figure 13.7. Kinetic signatures of the mechanisms of miRNA action. There are nine signatures corresponding to 
nine mechanisms. Each plot shows dynamics of three quantities: amount of mRNA (mRNA), average number of 
ribosomes per translated mRNA (RB), total amount of protein (Protein) in the time units measured in 1/kd. The 
dynamics on the left from the dashed line shows translation without miRNA which is added at the time point 20. 
Three scenarios are simulated for each signature: strong, medium and weak binding strength of miRNA to 
mRNA. The numbers on the graphs shows relative change in the steady state (ssmiRNA/ss) and change in the 
relaxation time (rt, measured in 1/kd). If three numbers are shown separated by comma, they correspond to weak, 
medium and strong miRNA binding. If only one number is shown, it means that the binding strength does not 
affect this quantity significantly. The diagrams on the right from the dynamics plot visualize values of six 
numbers (relative changes of steady state (SS) and relaxation time (RT) for three measurable quantities) for the 
case of medium binding strength. 
 
8.1. Fixed set of translation parameters and variable mixed mechanisms of miRNA 
action 
In Figure 13.8 we present the results of the following computational experiment. For a 
reference set of parameters (Table 13.3) we computed 625 kinetic signatures corresponding to 
all possible combinations of four mechanism strengths (s1, s2, s3, s7) at the level of 0%, 25%, 
50%, 75% and 100%. The signatures can be represented as a cloud of 625 points in the 6-
dimensional space of kinetic signatures, which was projected on a 2D plane using the 
standard principal components analysis (PCA). From the Figure 13.8 one can conclude that 
the first principal component PC1 is mainly associated with the change of ribosomal profile, 
while the second is mainly associated with degradation of mRNA. Therefore, position of 
“pure” mechanisms 60S Unit Joining Inhibition and Elongation Inhibition is placed at the 
maximum distance on the plot, while Cap Inhibition and Decay is located quite closely, 
because both do not change the ribosomal profile. However, one can show that Cap Inhibition 
and Decay pure mechanisms are separated along the third principle direction PC3, invisible 
on the plot. 
One of the important conclusions that can be made from the plot in the Figure 13.8 is that the 
presence of Decay mechanism in the spectrum (s7 > 0) can mask the effect of other 
mechanisms leading to the very early blockage of translation (M0M0’ dominant path). Indeed, 
it might not matter that a translation in the presence of miRNA is completely blocked at a 
later stage, if the increased degradation will destroy mRNA even before it can arrive at this 
blocked later stage. In some cases (such as the mixed mechanism F on the plot, co-existence 
of complete Cap Inhibition and Decay), the kinetic signature of the mixed mechanism is 
indistinguishable from Decay.  
 
 
 
Figure 13.8. PCA plot for simulations for a fixed set of translation parameters and a variable mixed mechanisms. 
The mix includes (1) Cap Inhibition, (2) 60S unit joining inhibition, (3) Elongation inhibition and (4) Decay for 
the reference set of translation parameters and kb = 10
-3. The plot represents a projection from a six-dimensional 
space of measurable quantities: relative changes in steady-state (SS) and relaxation time (RT) for three quantities: 
amount of mRNA (mRNA), number of ribosomes per mRNA (RB) and amount of protein (Protein). Each point 
represents a simulation made for a selected spectrum of strengths of four mechanisms, the colors distinguish the 
resulting dominant paths and the shapes distinguish spectrums when one of the mechanisms is dominating or 
when the mRNA decay is not affected by miRNA (circles). For example, red rectangle corresponds to the 
scenario when 60S unit joining is completely blocked if miRNA is bound, and M0M0’ dominant path is realized. 
Few points are annotated with signature diagrams visualizing the numerical values for the six variables. Four 
numbers on the left of each diagram show the strengths of four miRNA action mechanisms (cap inhibition, 60S 
unit joining inhibition, elongation inhibition and decay correspondingly). First two principal components explain 
86% of data variation. 
 
 The kinetic signature K (mix of 60S Unit Joining Inhibition and Elongation Inhibition) is 
indistinguishable from the pure signature of Elongation Inhibition. The kinetic signature H 
(mix of three first mechanisms without Decay) reminds pure 60S Unit Joining Inhibition 
mechanism. Cases F, K and H are three examples of kinetic signature masking (or 
domination) of one mechanism by another. 
In other cases the resulting kinetic signature of a mixed mechanism does not remind any 
signature of the four pure mechanisms: by contrast, certain superimposition of the kinetic 
signatures happens. Thus, the mixed mechanisms A (co-existence of complete 60S Unit 
Joining Inhibition and Decay) and E (co-existence of complete 60S Unit Joining Inhibition 
and Elongation inhibition) give the signature which looks like a superimposition of the kinetic 
signatures of the initial mechanisms. However, further addition of miRNA action mechanisms 
does not change the signature qualitatively. Thus, mix of all four mechanisms together (cases 
B, C) still looks like a mix of 60S Unit Joining Inhibition and Decay. Hence, one can say that 
in this case a superimposition of two kinetic signatures masks signatures of other 
mechanisms. 
Interestingly, the kinetic signature in the mixed mechanism J (mix of Cap Inhibition, 
Elongation Inhibition and Decay) can be still interpreted as a mix of three signatures of the 
initial pure mechanisms. This is an example, when three mechanisms are superimposed and 
leave their “traces” in the final mix. 
 
8.2. Fixed mixed mechanism of miRNA action and variable experimental or cellular 
context of translation 
In the second computational experiment we fixed the strengths of the four mechanisms at 
50%, i.e. we consider the mixed miRNA action mechanism characterized by the spectrum 
S = {0.5, 0.5, 0.5, 0, 0, 0, 0.5, 0, 0}. For the reference set of parameters and variable miRNA-
mRNA binding constant (see Figure 13.9, top left), this mixed mechanism of miRNA action 
is manifested by a kinetic signature which can be attributed to the Decay mechanism of 
miRNA action (M7). However, for other parameter combinations the kinetic signature of this 
mechanism can look differently and expose features of other mechanisms (see below). The 
main message of the example shown in Figure 13.9 is that variation of the parameters of 
translation mechanism can significantly change the interpretation of the kinetic signature 
when several mechanisms of miRNA action co-exist. 
We study the kinetic signatures of the mixed mechanism S = {0.5, 0.5, 0.5, 0, 0, 0, 0.5, 0, 0} 
when the kinetic parameters of the normal translation are varied in very large intervals (five 
orders of magnitude). We varied four kinetic rates kd, kb, k01, k2, leaving kt and kp fixed at the 
reference values and putting k3 = k2/6 to provide constant average number of 6 ribosomes 
sitting on one mRNA. The parameters took the following range of values: 
kd{10
-3,10-4,10-5,10-6,10-7}, kb,k01,k2{10
-1,10-2,10-3,10-4,10-5} in all possible combinations. 
From these combinations those were excluded that violated the condition of efficient 
translation (not dominated by degradation) kd << k01, k2, k3. As a result, we have tried 440 
different simulations for which we created kinetic signatures, characterized by 6 numbers, as 
previously. These signatures can be represented as a cloud of 440 points in the 6-dimensional 
space, which was projected on a 2D plane using the standard principal components analysis 
(PCA), see Figure 13.9. This figure represents a “portrait” of a mixed mechanism of miRNA 
action for all relevant parameter values, including the reference parameter values (points RW, 
RM, RS).  
The two-dimensional distribution of kinetic signatures shown in Figure 13.9 shows two 
tendencies. Moving from top right to bottom left corner (from point A to point E) corresponds 
to increasing relative value of the miRNA binging constant, leading to more complete 
inhibition of protein synthesis. Moving from top left to bottom right corner (from point F to 
point J) corresponds to changing mainly the relaxation time of the ribosomal profile. There is 
a third degree of freedom not shown in the figure and associated with the third principal 
component which is almost completely corresponds to the change in the protein synthesis 
relaxation time. Thus, some points located closely on the plot (such as points C and D) are in 
fact separated along the third principal component and have very different protein synthesis 
relaxation time values.  
 
 
 
Figure 13.9.  PCA plot (on the right) for simulations for one selected mixed mechanism (Cap Initiation 
Inhibition at 50%, 60S Unit Joining Inhibition at 50%, Elongation Inhibition at 50% and Decay at 50%) and a 
variable set of internal translation parameters. The plot represents a projection from six-dimensional space of 
measurable quantities: relative changes in steady-state (SS) and relaxation time (RT) for three quantities: amount 
of mRNA (mRNA), number of ribosomes per mRNA (RB) and amount of protein (Protein). Each point 
represents a simulation made for a combination of kd, kb, k01 and k2 parameter values, the color and shape 
distinguish the resulting dominant paths. Several points are annotated with signature diagrams visualizing the 
numerical values for the six variables (on the left).  Cases RW, RM and RS (top left) show close to the reference 
set values for three different miRNA binding rates (kb=10
-3,10-4,10-5). First two principal components explain 
79% of data variation. 
 
 
 
 
Several important conclusions can be made from this computational experiment, and the first 
one concerns the role of miRNA binding strength. Evidently, if kb is much smaller than the 
normal translation parameters kd, k01, k2 then miRNA binding does not affect the dynamics 
significantly and the “normal” M0F0MFRP dominant path is implemented (case A). In the 
case when the binding is significant but not very strong and comparable to kd, k01, k2 
parameters (competitive binding), the signature is masked by Decay-like pattern (case RW). 
The Decay mechanism masks all other mechanisms also in those combinations of parameters 
where k2 is faster than kd by several (three) orders of magnitude (cases RM and RS). In this 
case, the ribosomal profile is not perturbed by miRNA.    
The relaxation time of a protein changes in the signatures when the mRNA degradation rate 
becomes less than the degradation rate of the protein: kd << kp = 510
-6 (see formula (15)). 
Notice that for the reference set of parameters the protein is assumed to be more stable than a 
transcript, and the only “pure” signature where the relaxation time of the protein is affected by 
miRNA is Cotranslational Protein Degradation. If the protein is less stable than a transcript 
then this might create confusion in interpreting the signatures and suggesting activation of this 
mechanism while it is not functional in reality. 
The signatures B, C, D and E can be interpreted as a superimposition of 60S Unit Joining 
Inhibition with Decay, with possible role of Cap Inhibition. Elongation Inhibition mechanism 
leading to the increase of both RB steady state and relaxation time might be suspected in the 
signatures I and J even though the RB steady state does not change significantly (this can be 
attributed to a compensatory effect from mixing Elongation Inhibition with 60S Unit Joining). 
Signatures F, G and H suggest the role of 60S Unit Joining Inhibition (decreasing the 
ribosome profile relaxation time) which would be completely missed if one looks at the 
relative changes of the steady states only. 
Finally, let us notice the special role of the M0M0’ dominant path which can produce kinetic 
signatures very similar to other dominant paths (this is true both for Figure 13.8 and Figure 
13.9). Compare, for example, pairs of cases F and G, D and E. The dominant path M0M0’ 
requires relatively strong binding kb>>k01 and relatively fast degradation or slow initiation, 
which can be expressed as condition on parameters 1
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, where s1 and s7 are 
the strengths of the Cap Initiation Inhibition and Decay mechanisms respectively in the mixed 
mechanism.  In the case when s1 = s7 = 0.5, this gives a condition k01<<9kd, i.e. that the 
normal cap initiation rate should not exceed the normal degradation rate by more than two 
orders of magnitude (100-fold). This condition is satisfied for the points B, E, G and the 
reference set of parameters on the plot in the Figure 13.9. On the other hand, it can be shown 
that k01 is the least sensitive parameter affecting the relative changes of the steady states and 
relaxation times for the MT, RB and PR values (decreasing k01 can affect only the steady state 
of the protein and not other values, see (14)). Hence, for many kinetic signatures, given 
relatively strong miRNA binding constant, there is a possibility to implement the M0M0’ 
dominant path by slowing down k01 without a qualitative signature change. This non-intuitive 
conclusion can be verified experimentally. 
 
9. Concluding remarks 
MicroRNA mode of action is a highly controversial topic. Here, we used mathematical 
modelling and found that each of the suggested mechanisms has a specific signature (the 
predicted dynamics of 3 measurable variables of the translational process, namely, the time 
course of accumulation of protein and mRNA, and of ribososmal loading on the mRNA). 
These signatures provide a new tool for discriminating between distinct mechanisms. We thus 
propose the concept of a characteristic kinetic signature for miRNA modes of action. 
In addition, an essential conclusion of our analysis is that miRNA action will impact the final 
kinetic output only if it targets a sensitive parameter of the system.  
The hypothesis that microRNA action can have a visible impact on protein output only if it 
affects the rate-limiting step has already been suggested in [62] for inhibition of translational 
initiation. However, the notion of rate-limiting step becomes non-trivial when we consider 
complex networks (more complex than a linear chain or a cycle of monomolecular reactions). 
The mathematical model that we present here confirms the conclusions from [62], and 
extends them to all steps of microRNA action. The mathematical approach we have 
developed for analysis of this complex system uses the notion of dominant dynamical system, 
itself a generalization of the rate-limiting step concept to complex networks [22,23,90].  
In accordance with the general theory of dynamical limitation [22], we can take into account 
not only the steady-state rates of protein synthesis but also its relaxation time. For example, 
for a linear chain of reactions, the steady-state rate depends on the slowest kinetic rate 
parameter (rate-limiting step), whereas the relaxation time of the system depends on the 
second slowest kinetic rate parameter. 
The analysis of our results allowed us to suggest a unifying theory for miRNA modes of 
action: all proposed modes of action operate simultaneously, and the apparent mechanism 
that will be detected depends on a set of sensitive intrinsic parameters of the individual target 
mRNA under study. This hypothesis would explain the following set of observations: 1) that 
the same microRNA apparently uses distinct mechanisms on different targets (e.g. for let7: 
[11,54,55,69,83,]; for CXCR4: [29,67,84,85]; for miR16: [28,37];  for miR122: [35]); 2) that 
microRNA’s mode of action depends on the promoter under which the target mRNA is 
transcribed [42]; and 3) that the status of the cell affects the final observable mode of 
miRNAs action [8,47,81]. Moreover, the possibility of coexistence of two or several 
mechanisms has already been discussed and proven in the literature 
[15,16,19,47,69,81,87,91]. 
As already stated, our modelling results lead us to propose that, in individual biological 
systems, the relative abundance and/or activity of some set of intrinsic factors determines the 
apparent inhibition mechanism that will be detected. These factors are not related to the 
miRNA pathways, but intrinsically determine the sensitive parameters of the system. Indeed, 
RNA-binding proteins not related to the miRNA pathway have been shown to have a strong 
influence on the final outcome of miRNA regulation [56,59,74,88].  
A body of studies underscore the importance of intrinsic parameters of mRNAs. Revisiting 
theses studies in the framework of our model provides an explanation for most of the 
discrepancies in the literature. Thus, in most of the studies showing initiation inhibition, in 
vitro transcribed mRNAs (transfected into cells or studied directly in vitro) were used. In 
contrast, almost all data supporting elongation inhibition were obtaining in living cells, and 
thus with physiologically modified target mRNAs [29,40,55,69,80,85], with only one and 
very specific exception [53]. Similarly, most of the studies showing IRES-driven mRNAs as 
being refractory to microRNAs were carried out either in vitro [55] or using in vitro 
transcribed mRNAs transfected into cells [29,40.69], whereas the studies showing IRES-
driven mRNAs to be repressed by miRNAs were carried out with mRNAs transcribed in situ, 
inside cells [37,67]. In all these cases, the difference might come from the status of the target 
mRNA, rather than from any putative or actual differences in the microRNA machinery.  
Another example is the influence of splicing marks attached to mRNAs in vivo. The process 
of mRNA splicing leaves protein marks on mRNAs, which promotes the first round of 
translation at the initiation step [46,59]. These marks are dissociated during the first round of 
translation. Splicing marks, by increasing the initial initiations, would lead to higher initiation 
rates on intron-containing mRNAs [36]. Elongation would thus become a limiting step. In 
contrast, in vitro transcribed mRNAs lack splicing marks, resulting in a decreased initiation 
rate, which becomes limiting. Moreover, under in vitro conditions, initiation is highly 
dependent on the concentration of initiation factors, providing another possible explanation 
for discrepancies between in vitro studies.  
Another example is the dependence of miRNA effects on codon usage. MicroRNA action has 
been reported to act on initiation steps when codon usage is optimized for human translation 
[40,68], whereas, with non-optimized codons, microRNA was found to act on elongation 
[25,53,63,67]. This again might have something to do with different rates of elongation, 
elongation rates being, or not, among the set of limiting (sensitive) parameters for a given 
mRNA.  
Yet another example is the dependence of microRNA mode of action on the experimental 
procedure for transfection of the mRNA [53]. The transfection procedure is likely to influence 
the association of the target mRNA with mRNA-binding proteins, which, in turn, changes the 
sensitive parameters of the system, and hence the final outcome of microRNA action. 
All these and some other data clearly support the idea that the observed mode of action of a 
microRNA depends upon interplay between the intrinsic rates of the different steps of mRNA 
translation.  
In summary, our results provide a mathematical tool to discriminate between different 
miRNA modes of action. Moreover, we propose a unifying model in which the observed 
mode of action of a particular miRNA is dictated by the relationships among the intrinsic 
parameters of its target mRNA. We anticipate that the tool we have developed will promote 
better analysis of experimental data, and that our model will permit a better understanding of 
microRNA action. Most importantly, our hypothesis would explain most of the discrepancies 
in the corresponding literature. 
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